Skip to content

A Study on How Sleep Quality Affects Brain Function the Following Day

An Investigation into the Effects of Changes in Sleep Quality on Next-Day Brain Function - Sleep Quality-Brain Function Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061051
Enrollment
40
Registered
2026-04-01
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group A: Pharmaceutical X -&gt
Food Y Group B: Food Y -&gt
Pharmaceutical X

Sponsors

National Institutes for Quantum Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Individuals who have the capacity to provide written informed consent for participation in this study. 2. Male participants aged 18 years or older and under 40 years at the time of consent. 3. Individuals whose habitual caffeine intake is below the recommended amount for healthy adults (<400 mg/day). 4. Individuals who have no abnormalities in sleep or general health status. 5. Individuals who, within the 3 months prior to obtaining consent, have not habitually used tobacco that could affect sleep, have not received any sleep related medical treatment, and have not engaged in shift work or experienced travel across time zones. 6. Individuals judged by a physician (investigator or sub investigator) to have no health problems.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of serious physical illness or brain disorders in the past or present. 2. Individuals with drug dependence or alcohol dependence. 3. Individuals who are ineligible for MRI examinations(e.g., those with magnetic metal in the body such as tattoos or intraocular lenses, or those with claustrophobia or fear of darkness). 4. Individuals for whom caffeine intake is contraindicated. As a criterion, the description in the package insert of caffeine tablets-such as those regarding heart disease or excessive gastric acid secretion-must be followed. 5. Any other individuals deemed inappropriate as research participants by the physician who is also a researcher.

Design outcomes

Primary

MeasureTime frame
Correlations among sleep-quality indicators under caffeine and placebo conditions (such as total sleep time, wake after sleep onset, and sleep spindle duration), brain functional connectivity derived from resting-state fMRI and task-based fMRI during attention and memory tasks, cognitive task performance, and psychological assessment scores.

Countries

Japan

Contacts

Public ContactYasuka Sahara

National Institutes for Quantum Science and Technology Institute for Quantum Medical Science Dept. of Molecular Imaging and Theranostics

sahara.yasuka@qst.go.jp043-382-4304

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026